About Index Trending news
Analyze
Top 50 Pricing
AbSci

AbSci

AbSci

A company that has developed an E. coli expression system for optimized and scalable antibody and protein production.

Elsewhere

Alexa global traffic share

Twitter followers

11 Apr 2016
$5,100,000
Venture capital (Series A)
Phoenix Venture Partners

Biotech firm secures $5.1M to further work in proteins

Columbian.com